158 results on '"Rutigliano, Monica"'
Search Results
2. The Role of MUC1 in Renal Cell Carcinoma
3. Uridine and pyruvate protect T cells’ proliferative capacity from mitochondrial toxic antibiotics: a clinical pilot study
4. Characterization of Cytotoxic T Lymphocytes (CTL) by Tissue Microarray
5. Complement System and the Kidney: Its Role in Renal Diseases, Kidney Transplantation and Renal Cell Carcinoma
6. Cancer Stem Cells in Renal Cell Carcinoma: Origins and Biomarkers
7. Cellular and Molecular Players in the Tumor Microenvironment of Renal Cell Carcinoma
8. The dark side of lipid metabolism in prostate and renal carcinoma: novel insights into molecular diagnostic and biomarker discovery
9. MUC1 Expression Affects the Immunoflogosis in Renal Cell Carcinoma Microenvironment through Complement System Activation and Immune Infiltrate Modulation
10. β3 Adrenergic Receptor Agonist Mirabegron Increases AQP2 and NKCC2 Urinary Excretion in OAB Patients: A Pleiotropic Effect of Interest for Patients with X-Linked Nephrogenic Diabetes Insipidus
11. Emerging Hallmarks of Metabolic Reprogramming in Prostate Cancer
12. CTR2 Identifies a Population of Cancer Cells with Stem Cell-like Features in Patients with Clear Cell Renal Cell Carcinoma
13. Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets
14. MUC1 Tissue Expression and Its Soluble Form CA15-3 Identify a Clear Cell Renal Cell Carcinoma with Distinct Metabolic Profile and Poor Clinical Outcome
15. Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice.
16. Cryopreserved Penile Tunica Albuginea for Allotransplantation: A Morphological and Ultrastructural Investigation
17. Metabolomic Approaches for Detection and Identification of Biomarkers and Altered Pathways in Bladder Cancer
18. Novel Insights into Autophagy and Prostate Cancer: A Comprehensive Review
19. 206.Uridine and Pyruvate (Uripyr®) reduce immune cell dysfunctions during treatment with mitotoxic antibiotics
20. Novel Insights into the Molecular Mechanisms of Ischemia/Reperfusion Injury in Kidney Transplantation
21. Spondin-2, a Secreted Extracellular Matrix Protein, is a Novel Diagnostic Biomarker for Prostate Cancer
22. Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0 ng/ml
23. The Anti-Fibrotic Effect of Mycophenolic Acid–Induced Neutral Endopeptidase
24. Renal progenitor cells revert LPS‐induced endothelial‐to‐mesenchymal transition by secreting CXCL6, SAA4, and BPIFA2 antiseptic peptides
25. Microvascular density, macrophages, and mast cells in human clear cell renal carcinoma with and without bevacizumab treatment
26. Metabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: an update
27. Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma
28. Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma
29. MP067MICRORNA PROFILING USING NEXT-GENERATION SEQUENCING IN RENAL CANCER STEM CELLS: A NEW REGULATORY MECHANISM
30. SP168ARPCS CAN REVERT LPS-INDUCED ENDOTHELIAL-TO-MESENCHYMAL TRANSITION OF ENDOTHELIAL CELLS
31. TO007ADULT RENAL STEM/PROGENITOR CELLS EXPRESS LONG NON-CODING RNAS INVOLVED IN WNT AND THE BMP SIGNALING PATHWAY
32. Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma
33. Emerging Urinary Markers of Renal Injury in Obstructive Nephropathy
34. Renal Cell Carcinoma: A Study through NMR-Based Metabolomics Combined with Transcriptomics
35. The Three-Gene Signature in Urinary Extracellular Vesicles from Patients with Clear Cell Renal Cell Carcinoma
36. Loss of STK11 expression is an early event in prostate carcinogenesis and predicts therapeutic response to targeted therapy against MAPK/p38
37. Increased Expression of the Autocrine Motility Factor is Associated With Poor Prognosis in Patients With Clear Cell–Renal Cell Carcinoma
38. Soluble Serum αKlotho Is a Potential Predictive Marker of Disease Progression in Clear Cell Renal Cell Carcinoma
39. Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer
40. SP051EXOSOMAL SHUTTLE RNA IN URINARY EXTRACELLULAR VESICLES AS BIOMARKER OF CLEAR CELL RENAL CELL CARCINOMA
41. Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma
42. Pre-existing Type 2 Diabetes Mellitus Is an Independent Risk Factor for Mortality and Progression in Patients With Renal Cell Carcinoma
43. Diagnostic and Prognostic Role of Preoperative Circulating CA 15-3, CA 125, and Beta-2 Microglobulin in Renal Cell Carcinoma
44. Serum sarcosine is a risk factor for progression and survival in patients with metastatic castration-resistant prostate cancer
45. Regulation of TGF-β1 expression by Androgen Deprivation Therapy of prostate cancer
46. The Anti-Fibrotic Effect of Mycophenolic Acid–Induced Neutral Endopeptidase
47. Isolation and characterization of cancer stem cells in renal cell carcinoma.
48. RENAL CELL CARCINOMA: DOES TRANSCRIPTIONAL DEREGULATION OF ADULT RENAL STEM/PROGENITOR CELLS LEAD TO ONCOGENESIS?
49. Emerging Hallmarks of Metabolic Reprogramming in Prostate Cancer
50. Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.